CLINICAL_TRIALS
trial_result
· 2015-07-01
Clinical Trial Update: Methotrexate-Inadequate Response Autoinjector Device Sub Study [Phase 3]
Summary
Phase 3 methotrexate autoinjector sub-study in rheumatoid arthritis patients with inadequate response completed; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2015-07-01